After several reports of numerous flaws, Depuy Synthes, a subsidiary of Johnson & Johnson, has issued a recall for the Attune Knee system.
The Attune implant bypassed the rigorous pre-market acceptance procedure and has been fast-tracked through what’s referred to as the FDA’s approval procedure. You can also visit https://www.depuykneelawsuit.com/depuy-knee-lawsuits.aspx to know more about Depuy knee lawsuit.
This procedure means makers like DePuy need only show that their products are “substantially equal” to present devices in the marketplace.
The Attune augmentation was meant to enhance clinical results, provide patients with increased freedom, and decrease recovery rates following knee replacement operation. On the other hand, the augmentation has been associated with premature device failure, resulting in multiple debilitating complications.
People that have the Attune knee program now implanted have complained of early device failure. Though some patients have undergone apparatus failure one or two years following augmentation surgery, other patients underwent it just months following implant surgery. Along with premature collapse, the Attune implant may cause the following complications:
- Nerve harm
- Swelling around the knee joint
- Fracture of this apparatus
- Fracture of the femur or tibia
- Apparatus dislocation
- Reduced range of movement
- Steel shedding debris